151 related articles for article (PubMed ID: 7661751)
1. Early office-based vs late hospital-based nasolacrimal duct probing. A clinical decision analysis.
Kassoff J; Meyer DR
Arch Ophthalmol; 1995 Sep; 113(9):1168-71. PubMed ID: 7661751
[TBL] [Abstract][Full Text] [Related]
2. Nasolacrimal duct office probing in children under the age of 12 months: Cure rate and cost evaluation.
Le Garrec J; Abadie-Koebele C; Parienti JJ; Molgat Y; Degoumois A; Mouriaux F
J Fr Ophtalmol; 2016 Feb; 39(2):171-7. PubMed ID: 26826746
[TBL] [Abstract][Full Text] [Related]
3. Early office-based vs late hospital-based nasolacrimal duct probing.
Kushner BJ
Arch Ophthalmol; 1995 Sep; 113(9):1103-4. PubMed ID: 7661739
[No Abstract] [Full Text] [Related]
4. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
Cha DS; Lee H; Park MS; Lee JM; Baek SH
Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants: the importance of the spontaneous resolution rate.
Frick KD; Hariharan L; Repka MX; Chandler D; Melia BM; Beck RW;
Arch Ophthalmol; 2011 May; 129(5):603-9. PubMed ID: 21555614
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.
Pediatric Eye Disease Investigator Group
Arch Ophthalmol; 2012 Dec; 130(12):1525-33. PubMed ID: 23229693
[TBL] [Abstract][Full Text] [Related]
7. Office- or Facility-Based Probing for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
Morrison DG; Binenbaum G; Chang MY; Heidary G; Trivedi RH; Galvin JA; Pineles SL
Ophthalmology; 2021 Jun; 128(6):920-927. PubMed ID: 33358412
[TBL] [Abstract][Full Text] [Related]
8. Office probing of congenital nasolacrimal duct obstruction.
Stager D; Baker JD; Frey T; Weakley DR; Birch EE
Ophthalmic Surg; 1992 Jul; 23(7):482-4. PubMed ID: 1407947
[TBL] [Abstract][Full Text] [Related]
9. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
Hung CH; Chen YC; Lin SL; Chen WL
Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
[TBL] [Abstract][Full Text] [Related]
10. Probing for nasolacrimal duct obstruction with intravenous propofol sedation.
Movaghar M; Kodsi S; Merola C; Doyle J
J AAPOS; 2000 Jun; 4(3):179-82. PubMed ID: 10849396
[TBL] [Abstract][Full Text] [Related]
11. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
[TBL] [Abstract][Full Text] [Related]
12. Office probing for treatment of nasolacrimal duct obstruction in infants.
Miller AM; Chandler DL; Repka MX; Hoover DL; Lee KA; Melia M; Rychwalski PJ; Silbert DI; ; Beck RW; Crouch ER; Donahue S; Holmes JM; Quinn GE; Sala NA; Schloff S; Wallace DK; Foster NC; Frick KD; Golden RP; Lambert SR; Tien DR; Weakley DR
J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
[TBL] [Abstract][Full Text] [Related]
14. Pediatric nasolacrimal duct obstruction.
Schnall BM
Curr Opin Ophthalmol; 2013 Sep; 24(5):421-4. PubMed ID: 23846190
[TBL] [Abstract][Full Text] [Related]
15. Congenital nasolacrimal duct obstruction: natural history and the timing of optimal intervention.
Paul TO; Shepherd R
J Pediatr Ophthalmol Strabismus; 1994; 31(6):362-7. PubMed ID: 7714699
[TBL] [Abstract][Full Text] [Related]
16. Office probing for congenital nasolacrimal duct obstruction: a study of parental satisfaction.
Goldblum TA; Summers CG; Egbert JE; Letson RD
J Pediatr Ophthalmol Strabismus; 1996; 33(4):244-7. PubMed ID: 8827561
[TBL] [Abstract][Full Text] [Related]
17. Outcome of probing for congenital nasolacrimal duct obstruction in older children.
Honavar SG; Prakash VE; Rao GN
Am J Ophthalmol; 2000 Jul; 130(1):42-8. PubMed ID: 11004258
[TBL] [Abstract][Full Text] [Related]
18. Management of congenital nasolacrimal duct obstruction--latin american study.
Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
[TBL] [Abstract][Full Text] [Related]
19. The Role of Inferior Turbinate Fracture in the Management of Congenital Nasolacrimal Duct Obstruction.
Rajabi MT; Inanloo B; Salabati M; Rafizadeh M; Tabatabaie SZ; Bayat R; Mahmoudzadeh R
Ophthalmic Plast Reconstr Surg; 2019; 35(3):269-271. PubMed ID: 30234839
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry.
Oke I; Elze T; Miller JW; Lorch AC; Hunter DG; Elliott AT;
JAMA Ophthalmol; 2023 Apr; 141(4):342-348. PubMed ID: 36862386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
